Biologics, Biosimilars, and Biobetters

Biologics, Biosimilars, and Biobetters
Author :
Publisher : John Wiley & Sons
Total Pages : 328
Release :
ISBN-10 : 9781119564652
ISBN-13 : 1119564654
Rating : 4/5 (654 Downloads)

Book Synopsis Biologics, Biosimilars, and Biobetters by : Iqbal Ramzan

Download or read book Biologics, Biosimilars, and Biobetters written by Iqbal Ramzan and published by John Wiley & Sons. This book was released on 2021-02-03 with total page 328 pages. Available in PDF, EPUB and Kindle. Book excerpt: A comprehensive primer and reference, this book provides pharmacists and health practitioners the relevant science and policy concepts behind biologics, biosimilars, and biobetters from a practical and clinical perspective. Explains what pharmacists need to discuss the equivalence, efficacy, safety, and risks of biosimilars with physicians, health practitioners, and patients about Guides regulators on pragmatic approaches to dealing with these drugs in the context of rapidly evolving scientific and clinical evidence Balances scientific information on complex drugs with practical information, such as a checklist for pharmacists


Biologics, Biosimilars, and Biobetters Related Books

Biologics, Biosimilars, and Biobetters
Language: en
Pages: 328
Authors: Iqbal Ramzan
Categories: Medical
Type: BOOK - Published: 2021-02-03 - Publisher: John Wiley & Sons

DOWNLOAD EBOOK

A comprehensive primer and reference, this book provides pharmacists and health practitioners the relevant science and policy concepts behind biologics, biosimi
Biosimilars
Language: en
Pages: 713
Authors: Hiten J. Gutka
Categories: Medical
Type: BOOK - Published: 2018-12-13 - Publisher: Springer

DOWNLOAD EBOOK

This book provides a comprehensive overview of the biosimilar regulatory framework, the development process and clinical aspects for development of biosimilars.
Biosimilars
Language: en
Pages: 447
Authors: Shein-Chung Chow
Categories: Mathematics
Type: BOOK - Published: 2013-07-29 - Publisher: CRC Press

DOWNLOAD EBOOK

As many biological products face losing their patents in the next decade, the pharmaceutical industry needs an abbreviated regulatory pathway for approval of bi
Guide to Biosimilars Litigation and Regulation in the U.S.
Language: en
Pages: 0
Authors:
Categories: Drugs
Type: BOOK - Published: 2022 - Publisher:

DOWNLOAD EBOOK

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics
Language: en
Pages: 0
Authors: Lisa M.. Plitnick
Categories:
Type: BOOK - Published: 2015 - Publisher:

DOWNLOAD EBOOK